• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症的异质轨迹:神经发育和神经进展模型的见解。

Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models.

机构信息

Laboratório de Psiquiatria Molecular, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.

Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Departamento de Psiquiatria e Medicina Legal, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.

出版信息

Braz J Psychiatry. 2022 Jan-Feb;44(1):74-80. doi: 10.1590/1516-4446-2020-1670.

DOI:10.1590/1516-4446-2020-1670
PMID:33886948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8827372/
Abstract

The notion that schizophrenia is a neuroprogressive disorder is based on clinical perception of cumulative impairments over time and is supported by neuroimaging and biomarker research. Nevertheless, increasing evidence has indicated that schizophrenia first emerges as a neurodevelopmental disorder that could follow various pathways, some of them neuroprogressive. The objective of this review is to revisit basic research on cognitive processes and neuroimaging findings in a search for candidate keys to the intricate connections between neurodevelopment and neuroprogression in schizophrenia. In the complete panorama, schizophrenia is a neurodevelopmental disorder, possibly associated with an additional burden over the course of the disease through pathologically accelerated aging, and cognitive heterogeneity may explain the different trajectories of each patient.

摘要

精神分裂症是一种神经进行性疾病的观点基于临床对随时间推移而累积的损伤的感知,并且得到了神经影像学和生物标志物研究的支持。然而,越来越多的证据表明,精神分裂症最初是一种神经发育障碍,可能遵循多种途径,其中一些是神经进行性的。本综述的目的是重新审视认知过程的基础研究和神经影像学发现,以寻找精神分裂症中神经发育和神经进行之间复杂联系的候选关键因素。在完整的图景中,精神分裂症是一种神经发育障碍,可能与疾病过程中病理性加速老化有关的额外负担有关,认知异质性可能解释了每个患者的不同轨迹。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c6/8827372/c74fd049af7f/bjp-44-01-74-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c6/8827372/0d86d6b7101c/bjp-44-01-74-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c6/8827372/c74fd049af7f/bjp-44-01-74-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c6/8827372/0d86d6b7101c/bjp-44-01-74-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88c6/8827372/c74fd049af7f/bjp-44-01-74-g002.jpg

相似文献

1
Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models.精神分裂症的异质轨迹:神经发育和神经进展模型的见解。
Braz J Psychiatry. 2022 Jan-Feb;44(1):74-80. doi: 10.1590/1516-4446-2020-1670.
2
Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed.精神分裂症发病时的结构脑影像学:我们有哪些收获,又遗漏了什么。
Psychiatry Res. 2021 Jul;301:113962. doi: 10.1016/j.psychres.2021.113962. Epub 2021 Apr 24.
3
Brain gyrification in bipolar disorder: a systematic review of neuroimaging studies.双相情感障碍的大脑脑回发育:神经影像学研究的系统综述。
Brain Imaging Behav. 2022 Dec;16(6):2768-2784. doi: 10.1007/s11682-022-00713-x. Epub 2022 Aug 31.
4
Areas of controversy in neuroprogression in bipolar disorder.双相障碍神经进展中的争议领域。
Acta Psychiatr Scand. 2016 Aug;134(2):91-103. doi: 10.1111/acps.12581. Epub 2016 Apr 21.
5
A Systematic Review of the Human Accelerated Regions in Schizophrenia and Related Disorders: Where the Evolutionary and Neurodevelopmental Hypotheses Converge.精神分裂症及相关障碍的人类加速区的系统综述:进化和神经发育假说的交汇点。
Int J Mol Sci. 2023 Feb 10;24(4):3597. doi: 10.3390/ijms24043597.
6
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia.精神分裂症患者大脑发育不同阶段多种病理过程的结构性脑成像证据。
Schizophr Bull. 2005 Jul;31(3):672-96. doi: 10.1093/schbul/sbi034. Epub 2005 Jul 14.
7
Neurodevelopmental pathways in bipolar disorder.双相障碍的神经发育途径。
Neurosci Biobehav Rev. 2020 May;112:213-226. doi: 10.1016/j.neubiorev.2020.02.005. Epub 2020 Feb 5.
8
The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia.母体免疫激活在改变后代神经发育轨迹中的作用:神经影像学研究的转化综述及其对自闭症谱系障碍和精神分裂症的影响。
Neurosci Biobehav Rev. 2019 Sep;104:141-157. doi: 10.1016/j.neubiorev.2019.06.020. Epub 2019 Jun 29.
9
The Genesis of Schizophrenia: An Origin Story.精神分裂症的起源:一个起源故事。
Am J Psychiatry. 2024 Jun 1;181(6):482-492. doi: 10.1176/appi.ajp.20240305.
10
Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications.精神分裂症中的线粒体功能障碍:途径、机制及意义。
Neurosci Biobehav Rev. 2015 Jan;48:10-21. doi: 10.1016/j.neubiorev.2014.11.005. Epub 2014 Nov 15.

引用本文的文献

1
Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.精神分裂症谱系中的认知障碍:探索一般智力因素与社会人口统计学、精神病理学、神经发育及遗传学之间的关系。
Psychol Med. 2024 Dec 2;54(15):1-12. doi: 10.1017/S0033291724002538.
2
The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia.精神分裂症患者外周血微小核糖核酸表达水平与人格障碍的相关性
Alpha Psychiatry. 2024 Jan 1;25(1):23-29. doi: 10.5152/alphapsychiatry.2024.231216. eCollection 2024 Jan.
3

本文引用的文献

1
Executive deficits in schizophrenia: mediation by processing speed and its relationships with aging.精神分裂症的执行功能缺陷:加工速度的中介作用及其与衰老的关系。
Psychol Med. 2022 Apr;52(6):1126-1134. doi: 10.1017/S0033291720002871. Epub 2020 Aug 25.
2
The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium.精神分裂症患者及健康参与者的大脑白质微观结构与一般认知能力的关系:ENIGMA 联合会研究
Am J Psychiatry. 2020 Jun 1;177(6):537-547. doi: 10.1176/appi.ajp.2019.19030225. Epub 2020 Mar 26.
3
Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum.
Biomarkers of neurodegeneration in schizophrenia: systematic review and meta-analysis.
精神分裂症神经退行性生物标志物的系统评价和荟萃分析。
BMJ Ment Health. 2024 May 24;27(1):e301017. doi: 10.1136/bmjment-2024-301017.
4
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review.5-羟色胺和多巴胺活性调节剂治疗精神分裂症阴性症状的疗效:快速综述
Biomedicines. 2023 Mar 16;11(3):921. doi: 10.3390/biomedicines11030921.
5
Subjective Overview of Accelerated Aging in Schizophrenia.精神分裂症加速老化的主观概述。
Int J Environ Res Public Health. 2022 Dec 31;20(1):737. doi: 10.3390/ijerph20010737.
精神分裂症谱系中未用药个体的认知障碍
JAMA Psychiatry. 2020 May 1;77(5):543-545. doi: 10.1001/jamapsychiatry.2020.0001.
4
A pilot study of biomarkers of oxidative stress in serum and schizophrenia.血清氧化应激生物标志物与精神分裂症的初步研究。
Psychiatry Res. 2020 Feb;284:112757. doi: 10.1016/j.psychres.2020.112757. Epub 2020 Jan 11.
5
A Systematic Review of Studies Reporting Data-Driven Cognitive Subtypes across the Psychosis Spectrum.一项对跨精神病谱系报告数据驱动认知亚型的研究的系统评价。
Neuropsychol Rev. 2020 Dec;30(4):446-460. doi: 10.1007/s11065-019-09422-7. Epub 2019 Dec 18.
6
Neuroimaging in Schizophrenia.精神分裂症的神经影像学研究。
Neuroimaging Clin N Am. 2020 Feb;30(1):73-83. doi: 10.1016/j.nic.2019.09.007. Epub 2019 Nov 11.
7
Influence of cognitive reserve in schizophrenia: A systematic review.精神分裂症认知储备的影响:系统评价。
Neurosci Biobehav Rev. 2020 Jan;108:149-159. doi: 10.1016/j.neubiorev.2019.10.019. Epub 2019 Nov 2.
8
Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms.精神病和精神分裂症超高风险人群的认知特征:使用协调常模的比较
Front Psychiatry. 2019 Oct 1;10:695. doi: 10.3389/fpsyt.2019.00695. eCollection 2019.
9
Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.精神分裂症和双相情感障碍中的神经认知内表型:纵向家族研究的系统综述
Schizophr Res. 2019 Aug;210:21-29. doi: 10.1016/j.schres.2019.06.014. Epub 2019 Jul 1.
10
Brain structure and cognitive ability in healthy aging: a review on longitudinal correlated change.脑结构与认知能力在健康老龄化中的变化:纵向关联研究综述
Rev Neurosci. 2019 Dec 18;31(1):1-57. doi: 10.1515/revneuro-2018-0096.